他折派特
|
|
- CAS号:
- 141374-81-4
- 英文名:
- tarazepide
- 英文别名:
- tarazepide;4H-Pyrrolo[3,2,1-ij]quinoline-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-5,6-dihydro-
- 中文名:
- 他折派特
- 中文别名:
- 他折派特;化合物 T13084
- CBNumber:
- CB51393722
- 分子式:
- C28H24N4O2
- 分子量:
- 448.524
- MOL File:
- 141374-81-4.mol
|
|
|
他折派特化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
他折派特性质、用途与生产工艺
Tarazepide 是一种有效且特异性的 CCK-A 受体拮抗剂。
Tarazepide decreases duodenal electric activity, reduces interdigestive pancreatic secretion, especially protein; reduces cephalic and early postprandial (milk) induced secretion of bicarbonate and protein.Pancreatic protein secretion to intravenous CCK-8 was little affected by atropine, but was significantly reduced by Tarazepide±Atropine; in contrast, protein secretion to intraduodenal CCK-8 was abolished by Tarazepide or atropine. Leptin is administered to the animals at doses of 0.1, 1.0 or 10.0 μg/kg i.d. Tarazepide (2.5 mg/kg, i.d.), a CCK(1) receptor antagonist, is given to the rats prior to the application of leptin. CCK plasma level is measured by radioimmunoassay (RIA) following administration of leptin to the rats. Intraduodenal administration of leptin (1.0 or 10.0 microg/kg) to the fasted rats significantly and dose-dependently increases pancreatic protein and amylase outputs. Pancreatic secretory responses to leptin were totally abolished by prior capsaicin deactivation of sensory nerves or by pretreatment of the rats with Tarazepide.
他折派特
上下游产品信息
上游原料
下游产品
141374-81-4, 他折派特 相关搜索:
- 化合物 T13084
- 他折派特
- 141374-81-4
- 4H-Pyrrolo[3,2,1-ij]quinoline-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-5,6-dihydro-
- tarazepide